永太科技(002326.SZ)：利丙双卡因乳膏获得药品注册证书

Core Viewpoint - Yongtai Technology (002326.SZ) has received approval from the National Medical Products Administration for the registration of its compound drug, Ropivacaine and Lidocaine Cream, which is intended for local anesthesia in specific medical procedures [1] Group 1: Product Approval - Yongtai Technology's wholly-owned subsidiary, Binhai Meikang Pharmaceutical Co., Ltd., has been granted a drug registration certificate for Ropivacaine and Lidocaine Cream by the National Medical Products Administration [1] - The cream is a compound formulation of Lidocaine and Ropivacaine, designed for local anesthesia in various situations [1] Group 2: Indications for Use - The cream is indicated for local anesthesia in procedures such as needle punctures (e.g., catheter insertion or blood sampling) [1] - It is also used for superficial surgical procedures, including those involving the genital mucosa and for cleaning/debridement of leg ulcers [1]